A word from our CEO, Mark Wilson

"Cochrane's main challenge at the moment is the funding threat faced by Cochrane Canada following the decision of the CIHR to end its current form of support. We've been supporting the efforts of Cochrane Canada to find alternate sources of funding support in 2016 and beyond. And I want to salute the work of Jeremy Grimshaw, Holger Schunemann, Jordi Pardo and all of their Canadian Cochrane colleagues in this regard. We think the loss of this funding is an exceptional situation - having no relevance to the outstanding performance of the Cochrane Canada Centres and Groups."

- Mark Wilson, speaking to the 23rd Annual Cochrane Colloquium in Vienna, October 2015 

Mark Wilson